Marble Bone Disease: a Rare Bone Disorder
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Inherited Renal Tubulopathies—Challenges and Controversies
G C A T T A C G G C A T genes Review Inherited Renal Tubulopathies—Challenges and Controversies Daniela Iancu 1,* and Emma Ashton 2 1 UCL-Centre for Nephrology, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK 2 Rare & Inherited Disease Laboratory, London North Genomic Laboratory Hub, Great Ormond Street Hospital for Children National Health Service Foundation Trust, Levels 4-6 Barclay House 37, Queen Square, London WC1N 3BH, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-2381204172; Fax: +44-020-74726476 Received: 11 February 2020; Accepted: 29 February 2020; Published: 5 March 2020 Abstract: Electrolyte homeostasis is maintained by the kidney through a complex transport function mostly performed by specialized proteins distributed along the renal tubules. Pathogenic variants in the genes encoding these proteins impair this function and have consequences on the whole organism. Establishing a genetic diagnosis in patients with renal tubular dysfunction is a challenging task given the genetic and phenotypic heterogeneity, functional characteristics of the genes involved and the number of yet unknown causes. Part of these difficulties can be overcome by gathering large patient cohorts and applying high-throughput sequencing techniques combined with experimental work to prove functional impact. This approach has led to the identification of a number of genes but also generated controversies about proper interpretation of variants. In this article, we will highlight these challenges and controversies. Keywords: inherited tubulopathies; next generation sequencing; genetic heterogeneity; variant classification. 1. Introduction Mutations in genes that encode transporter proteins in the renal tubule alter kidney capacity to maintain homeostasis and cause diseases recognized under the generic name of inherited tubulopathies. -
SKELETAL DYSPLASIA Dr Vasu Pai
SKELETAL DYSPLASIA Dr Vasu Pai Skeletal dysplasia are the result of a defective growth and development of the skeleton. Dysplastic conditions are suspected on the basis of abnormal stature, disproportion, dysmorphism, or deformity. Diagnosis requires Simple measurement of height and calculation of proportionality [<60 inches: consideration of dysplasia is appropriate] Dysmorphic features of the face, hands, feet or deformity A complete physical examination Radiographs: Extremities and spine, skull, Pelvis, Hand Genetics: the risk of the recurrence of the condition in the family; Family evaluation. Dwarf: Proportional: constitutional or endocrine or malnutrition Disproportion [Trunk: Extremity] a. Height < 42” Diastrophic Dwarfism < 48” Achondroplasia 52” Hypochondroplasia b. Trunk-extremity ratio May have a normal trunk and short limbs (achondroplasia), Short trunk and limbs of normal length (e.g., spondylo-epiphyseal dysplasia tarda) Long trunk and long limbs (e.g., Marfan’s syndrome). c. Limb-segment ratio Normal: Radius-Humerus ratio 75% Tibia-Femur 82% Rhizomelia [short proximal segments as in Achondroplastics] Mesomelia: Dynschondrosteosis] Acromelia [short hands and feet] RUBIN CLASSIFICATION 1. Hypoplastic epiphysis ACHONDROPLASTIC Autosomal Dominant: 80%; 0.5-1.5/10000 births Most common disproportionate dwarfism. Prenatal diagnosis: 18 weeks by measuring femoral and humeral lengths. Abnormal endochondral bone formation: zone of hypertrophy. Gene defect FGFR fibroblast growth factor receptor 3 . chromosome 4 Rhizomelic pattern, with the humerus and femur affected more than the distal extremities; Facies: Frontal bossing; Macrocephaly; Saddle nose Maxillary hypoplasia, Mandibular prognathism Spine: Lumbar lordosis and Thoracolumbar kyphosis Progressive genu varum and coxa valga Wedge shaped gaps between 3rd and 4th fingers (trident hands) Trident hand 50%, joint laxity Pathology Lack of columnation Bony plate from lack of growth Disorganized metaphysis Orthopaedics 1. -
Prevalence and Incidence of Rare Diseases: Bibliographic Data
Number 1 | January 2019 Prevalence and incidence of rare diseases: Bibliographic data Prevalence, incidence or number of published cases listed by diseases (in alphabetical order) www.orpha.net www.orphadata.org If a range of national data is available, the average is Methodology calculated to estimate the worldwide or European prevalence or incidence. When a range of data sources is available, the most Orphanet carries out a systematic survey of literature in recent data source that meets a certain number of quality order to estimate the prevalence and incidence of rare criteria is favoured (registries, meta-analyses, diseases. This study aims to collect new data regarding population-based studies, large cohorts studies). point prevalence, birth prevalence and incidence, and to update already published data according to new For congenital diseases, the prevalence is estimated, so scientific studies or other available data. that: Prevalence = birth prevalence x (patient life This data is presented in the following reports published expectancy/general population life expectancy). biannually: When only incidence data is documented, the prevalence is estimated when possible, so that : • Prevalence, incidence or number of published cases listed by diseases (in alphabetical order); Prevalence = incidence x disease mean duration. • Diseases listed by decreasing prevalence, incidence When neither prevalence nor incidence data is available, or number of published cases; which is the case for very rare diseases, the number of cases or families documented in the medical literature is Data collection provided. A number of different sources are used : Limitations of the study • Registries (RARECARE, EUROCAT, etc) ; The prevalence and incidence data presented in this report are only estimations and cannot be considered to • National/international health institutes and agencies be absolutely correct. -
X-Linked Diseases: Susceptible Females
REVIEW ARTICLE X-linked diseases: susceptible females Barbara R. Migeon, MD 1 The role of X-inactivation is often ignored as a prime cause of sex data include reasons why women are often protected from the differences in disease. Yet, the way males and females express their deleterious variants carried on their X chromosome, and the factors X-linked genes has a major role in the dissimilar phenotypes that that render women susceptible in some instances. underlie many rare and common disorders, such as intellectual deficiency, epilepsy, congenital abnormalities, and diseases of the Genetics in Medicine (2020) 22:1156–1174; https://doi.org/10.1038/s41436- heart, blood, skin, muscle, and bones. Summarized here are many 020-0779-4 examples of the different presentations in males and females. Other INTRODUCTION SEX DIFFERENCES ARE DUE TO X-INACTIVATION Sex differences in human disease are usually attributed to The sex differences in the effect of X-linked pathologic variants sex specific life experiences, and sex hormones that is due to our method of X chromosome dosage compensation, influence the function of susceptible genes throughout the called X-inactivation;9 humans and most placental mammals – genome.1 5 Such factors do account for some dissimilarities. compensate for the sex difference in number of X chromosomes However, a major cause of sex-determined expression of (that is, XX females versus XY males) by transcribing only one disease has to do with differences in how males and females of the two female X chromosomes. X-inactivation silences all X transcribe their gene-rich human X chromosomes, which is chromosomes but one; therefore, both males and females have a often underappreciated as a cause of sex differences in single active X.10,11 disease.6 Males are the usual ones affected by X-linked For 46 XY males, that X is the only one they have; it always pathogenic variants.6 Females are biologically superior; a comes from their mother, as fathers contribute their Y female usually has no disease, or much less severe disease chromosome. -
April 2020 Radar Diagnoses and Cohorts the Following Table Shows
RaDaR Diagnoses and Cohorts The following table shows which cohort to enter each patient into on RaDaR Diagnosis RaDaR Cohort Adenine Phosphoribosyltransferase Deficiency (APRT-D) APRT Deficiency AH amyloidosis MGRS AHL amyloidosis MGRS AL amyloidosis MGRS Alport Syndrome Carrier - Female heterozygote for X-linked Alport Alport Syndrome (COL4A5) Alport Syndrome Carrier - Heterozygote for autosomal Alport Alport Syndrome (COL4A3, COL4A4) Alport Syndrome Alport Anti-Glomerular Basement Membrane Disease (Goodpastures) Vasculitis Atypical Haemolytic Uraemic Syndrome (aHUS) aHUS Autoimmune distal renal tubular acidosis Tubulopathy Autosomal recessive distal renal tubular acidosis Tubulopathy Autosomal recessive proximal renal tubular acidosis Tubulopathy Autosomal Dominant Polycystic Kidney Disease (ARPKD) ADPKD Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) ADTKD Autosomal Recessive Polycystic Kidney Disease (ARPKD) ARPKD/NPHP Bartters Syndrome Tubulopathy BK Nephropathy BK Nephropathy C3 Glomerulopathy MPGN C3 glomerulonephritis with monoclonal gammopathy MGRS Calciphylaxis Calciphylaxis Crystalglobulinaemia MGRS Crystal-storing histiocytosis MGRS Cystinosis Cystinosis Cystinuria Cystinuria Dense Deposit Disease (DDD) MPGN Dent Disease Dent & Lowe Denys-Drash Syndrome INS Dominant hypophosphatemia with nephrolithiasis or osteoporosis Tubulopathy Drug induced Fanconi syndrome Tubulopathy Drug induced hypomagnesemia Tubulopathy Drug induced Nephrogenic Diabetes Insipidus Tubulopathy Epilepsy, Ataxia, Sensorineural deafness, Tubulopathy -
Blueprint Genetics Comprehensive Skeletal Dysplasias and Disorders
Comprehensive Skeletal Dysplasias and Disorders Panel Test code: MA3301 Is a 251 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of disorders involving the skeletal system. About Comprehensive Skeletal Dysplasias and Disorders This panel covers a broad spectrum of skeletal disorders including common and rare skeletal dysplasias (eg. achondroplasia, COL2A1 related dysplasias, diastrophic dysplasia, various types of spondylo-metaphyseal dysplasias), various ciliopathies with skeletal involvement (eg. short rib-polydactylies, asphyxiating thoracic dysplasia dysplasias and Ellis-van Creveld syndrome), various subtypes of osteogenesis imperfecta, campomelic dysplasia, slender bone dysplasias, dysplasias with multiple joint dislocations, chondrodysplasia punctata group of disorders, neonatal osteosclerotic dysplasias, osteopetrosis and related disorders, abnormal mineralization group of disorders (eg hypopohosphatasia), osteolysis group of disorders, disorders with disorganized development of skeletal components, overgrowth syndromes with skeletal involvement, craniosynostosis syndromes, dysostoses with predominant craniofacial involvement, dysostoses with predominant vertebral involvement, patellar dysostoses, brachydactylies, some disorders with limb hypoplasia-reduction defects, ectrodactyly with and without other manifestations, polydactyly-syndactyly-triphalangism group of disorders, and disorders with defects in joint formation and synostoses. Availability 4 weeks Gene Set Description -
Case Report Osteopetrosis Complicated by Schizophrenia Results from Mutations on Chromosome 16
Int J Clin Exp Med 2016;9(9):18673-18677 www.ijcem.com /ISSN:1940-5901/IJCEM0016860 Case Report Osteopetrosis complicated by schizophrenia results from mutations on Chromosome 16 Yuwei Zhang, Decai Chen, Fang Zhang, Qingguo Lv, Lizhi Tang, Nanwei Tong Division of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan, China Received September 25, 2015; Accepted December 8, 2015; Epub September 15, 2016; Published September 30, 2016 Abstract: Objective: To investigate the genetic pathogenesis and diagnosis of osteopetrosis, and its relationship with schizophrenia. Methods: Conducting extensive review of literature related to osteopetrosis patients with schizophre- nia, summing common disease genes and diagnosis of osteopetrosis in association with schizophrenia. Results and Conclusion: Osteopetrosis is a rare inherited metabolic bone disease, with 12 kinds of common disease genes. In particular, mutations at 16p13.3 are closely related to schizophrenia. In recent years, molecular studies have identified three genes on chromosome 16 closely associated with schizophrenia, located at 16p13.3, 16p11.2, 16p13.11. Thus osteopetrosis and schizophrenia may not be two independent diseases, and understanding their relationship may help to identify schizophrenia at an earlier stage in osteopetrosis patients with mutations of chro- mosome 16. Conversely, patients with a family history of schizophrenia may be at increased risk for developing osteopetrosis. Keywords: Osteopetrosis, schizophrenia, pathogenic gene, diagnosis Introduction the possibility of such an association in the present case study of a patient diagnosed with Osteopetrosis is an extremely rare hereditary both disorders and possessing common identi- metabolic bone disease characterized by a fied genetic mutations. In this study, the patient decrease in number or functionality of osteo- was given a written informed consent. -
Craniosynostosis Precision Panel Overview Indications Clinical Utility
Craniosynostosis Precision Panel Overview Craniosynostosis is defined as the premature fusion of one or more cranial sutures, often resulting in abnormal head shape. It is a developmental craniofacial anomaly resulting from a primary defect of ossification (primary craniosynostosis) or, more commonly, from a failure of brain growth (secondary craniosynostosis). As well, craniosynostosis can be simple when only one suture fuses prematurely or complex/compound when there is a premature fusion of multiple sutures. Complex craniosynostosis are usually associated with other body deformities. The main morbidity risk is the elevated intracranial pressure and subsequent brain damage. When left untreated, craniosynostosis can cause serious complications such as developmental delay, facial abnormality, sensory, respiratory and neurological dysfunction, eye anomalies and psychosocial disturbances. In approximately 85% of the cases, this disease is isolated and nonsyndromic. Syndromic craniosynostosis usually present with multiorgan complications. The Igenomix Craniosynostosis Precision Panel can be used to make a directed and accurate diagnosis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved. Indications The Igenomix Craniosynostosis Precision Panel is indicated for those patients with a clinical diagnosis or suspicion with or without the following manifestations: ‐ Microcephaly ‐ Scaphocephaly (elongated head) ‐ Anterior plagiocephaly ‐ Brachycephaly ‐ Torticollis ‐ Frontal bossing Clinical Utility The clinical utility of this panel is: - The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient. - Early initiation of treatment in the form surgical procedures to relieve fused sutures, midface advancement, limited phase of orthodontic treatment and combined 1 orthodontics/orthognathic surgery treatment. -
A Diagnostic Approach to Skeletal Dysplasias
CHAPTER 16 A Diagnostic Approach to Skeletal Dysplasias SHEILA UNGER,ANDREA SUPERTI-FURGA,and DAVID L. RIMOIN [AU1] INTRODUCTION and outlines some of the more important radiographic ®ndings. The skeletal dysplasias are disorders characterized by developmental abnormalities of the skeleton. They form a large heterogeneous group and range in severity from BACKGROUND precocious osteoarthropathy to perinatal lethality [1,2]. Disproportionate short stature is the most frequent clin- Each skeletal dysplasia is rare, but collectively the ical complication but is not uniformly present. There are birth incidence is approximately 1/5000 [4,5]. The ori- more than 100 recognized forms of skeletal dysplasia, ginal classi®cation of skeletal dysplasias was quite sim- which can make determining a speci®c diagnosis dif®cult plistic. Patients were categorized as either short trunked [1]. This process is further complicated by the rarity of (Morquio syndrome) or short limbed (achondroplasia) the individual conditions. The establishment of a precise [6] (Fig. 1). As awareness of these conditions grew, their diagnosis is important for numerous reasons, including numbers expanded to more than 200 and this gave rise to prediction of adult height, accurate recurrence risk, pre- an unwieldy and complicated nomenclature [7]. In 1977, natal diagnosis in future pregnancies, and, most import- N. Butler made the prophetic statement that ``in recent ant, for proper clinical management. Once a skeletal years, attempts to classify bone dysplasias have been dysplasia is suspected, clinical and radiographic indica- more proli®c than enduring'' [8]. The advent of molecu- tors, along with more speci®c biochemical and molecular lar testing allowed the grouping of some dysplasias into tests, are employed to determine the underlying diagno- families. -
Autosomal Dominant Osteopetrosis (ADO) Service At
Bristol Genetics Laboratory is a UKAS accredited medical laboratory No.9307. Autosomal Recessive/Infantile/Malignant Osteopetrosis (ARO) Autosomal Dominant/late-onset Osteopetrosis (ADO) (Albers-Schonberg disease) Clinical Background and Genetics Contact details: The osteopetroses are a heterogeneous group of disorders characterized by an Bristol Genetics Laboratory increased bone density due to impaired bone resorption. Pathology Sciences Southmead Hospital AR malignant infantile osteopetrosis (ARO) typically results in severe disease in Bristol, BS10 5NB infancy (OMIM 259700), patients may present with generalized increase in bone Enquiries: 0117 414 6168 density, predisposition to bone fractures, osteomyelitis, macrocephaly, frontal FAX: 0117 414 6464 bossing, progressive deafness and blindness, hepatosplenomegaly, and severe anaemia/pancytopenia. Incidence is 1:250,000 in UK Head of Department: ADO presents primarily with skeletal fractures and osteomyelitis from late Professor Rachel Butler, FRCPath childhood to adulthood. Hearing/visual loss may affect around 5% of individuals. Consultant Clinical Scientist Non-penetrance of ADO has long been recognized, with an estimated 1/3 of individuals inheriting a CLCN7 pathogenic variant NOT manifesting the ADO phenotype. Members of the same family carrying the same gene variant can Consultant Lead for Rare Disease: therefore have extremely variable presentation. This may be due to modifier Maggie Williams, FRCPath genes Consultant Lead for Oncology: At least 10 genes are thought to account for 70% of all osteopetrosis cases, with 7 accounting for 80% of ARO cases. TNFSF11 (RANKL) and TNFRSF11A Christopher Wragg, FRCPath (RANK) pathogenic variants are associated with reduced numbers of osteoclasts. A proportion of cases remain unidentified, implying further as yet Service Lead: unknown genes are involved in the disease. -
NGS Panels 2020
NGS Panels 2020 BENEFIT FROM OUR MEDICAL EXPERTISE AND STREAMLINED GENETIC TESTING NGS Panels 2020 Benefit from our Medical Expertise and Streamlined Genetic Testing CENTOGENE is fully committed to bringing the best possible diagnostic solutions to our patients and their families. We always strive to incorporate the latest in-house findings and medical research in our products to improve and ease the diagnostic odyssey of rare disease patients. To reflect the fast-growing knowledge of complex associations of genes with diseases as well as to maximize clinical sensitivity, we have updated and significantly redesigned our Next Generation Sequencing (NGS) gene panels. The gene composition of each panel has been revised to meet the latest gene discoveries as well as to provide the highest clinical validity. Additionally, we have minimized complexity and removed redundancy in the panel portfolio by creating phenotype-directed diagnostic panels, which are the most comprehensive and include all relevant genes necessary for differential diagnosis of syndromes with overlapping phenotype, therefore allowing the diagnosis of diseases that otherwise would be missed. This principle increases the clinical utility, de-risks panel choice, increases cost-effectiveness, and ultimately simplifies the diagnostic process. When choosing one of our NGS panels, feel confident that you will receive high-quality sequencing combined with best data analysis and interpretation, which are documented in comprehensive medical reports. As always, CENTOGENE and our Customer -
Osteopetrosis: Classification, Pathomorphology, Genetic Disorders, Clinical Manifestations (Literature Review and Clinical Case Report)
Практична медицина / Practical Medicine УДК 616.71-003.84 DOI: 10.22141/2224-1507.9.2.2019.172125 V.V. Povoroznyuk, N.V. Dedukh, M.A. Bystrytska, A.S. Musiienko State Institution “D.F. Chebotarev Institute of Gerontology of NAMS of Ukraine”, Kyiv, Ukraine Osteopetrosis: classification, pathomorphology, genetic disorders, clinical manifestations (literature review and clinical case report) For cite: Bol', sustavy, pozvonočnik. 2019;9(2):135-142. doi: 10.22141/2224-1507.9.2.2019.172125 Abstract. Osteopetrosis is a hereditary disease with an autosomal recessive or autosomal dominant type of in- heritance, caused by a disruption in the functional activity of osteoclasts due to gene mutation. The article sys- tematizes data on etiology, classification, pathomorphology, gene disorders based on the analysis of 38 sources of literature, and deals with the modern approa ches to the treatment of osteopetrosis. Three types of osteopetrosis with different severity degrees of skeletal disorders and pathological severity are described. The main pathomor- phological changes in the structural organization of bone tissue are presented and features of the state of osteo- clasts are shown depending on the mutation of genes controlling their functional activity. There are no protocols for the treatment of this pathology, but treatment me thods based on the use of hematopoietic stem cells are under development. The paper presents with clinical case report of a patient with marble bone disease. Keywords: osteopetrosis; classification; pathomorphology; osteoclasts; gene disorders; diagnosis; treatment Introduction osteopetrosis, osteoclasts, etiology, classification, genetic Osteopetrosis was first described by Albers-Schönberg disorders, treatment. in 1904 [1]. Osteopetrosis (congenital family osteoscle- rosis, marble bone disease, Albers-Schönberg disease) Osteopetrosis’ etiology is an umbrella term for a range of rare isolated inherited Osteopetrosis’ etiology and pathogenesis require a fur- disorders characterized by skeletal sclerosis [2, 3, 4, 5, 6, ther study.